What's breaking now, across thousands of outlets.
Plus news about Biogen and Gate Bioscience. Genmab shares ovarian cancer data for Rina-S: The drugmaker's FRα-directed ADC attained a 45.9% objective response rate in patients with platinum-resistant ovarian cancer (PROC) ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The glymphatic system is the brain's recently discovered network for flushing out toxins. Now, we're uncovering surprising ways to boost it to protect brain health
JSA, Working Group on Access to Medicines and Treatment call for ceilings on hospital charges and trade margins; they say absence of a uniform mechanism to regulate hospital charges had left patients…
(MedPage Today) -- While most cases of foreign body retrieval involve the upper gastrointestinal tract (GI), a young woman needed a colonoscopy after she intentionally swallowed multiple nails…
Dr Sunu explained that breast cancer is the most common cancer that affects women in Ghana.
Vaxcyte's shares {$PCVX} jumped 35% Monday morning after the company announced that its experimental pneumococcal vaccine VAX-31 met its key endpoints in a Phase 3 trial with adults, a major step in…
